↓ Skip to main content

High expression of miR-214 is associated with a worse disease-specific survival of the triple-negative breast cancer patients

Overview of attention for article published in Hereditary Cancer in Clinical Practice, February 2015
Altmetric Badge

Mentioned by

twitter
1 tweeter

Citations

dimensions_citation
13 Dimensions

Readers on

mendeley
21 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
High expression of miR-214 is associated with a worse disease-specific survival of the triple-negative breast cancer patients
Published in
Hereditary Cancer in Clinical Practice, February 2015
DOI 10.1186/s13053-015-0028-z
Pubmed ID
Authors

Dagnija Kalniete, Miki Nakazawa-Miklaševiča, Ilze Štrumfa, Arnis Āboliņš, Arvīds Irmejs, Jānis Gardovskis, Edvīns Miklaševičs

Abstract

Hereditary triple-negative breast cancer patients have better recurrence-free survival than triple-negative sporadic ones. High expression of some of the miRNAs is related to worse overall and disease-free survival of triple-negative breast cancer patients. The attempt to associate expression level of some miRNA in triple-negative hereditary and sporadic breast cancers to disease specific survival was performed in this study.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 21 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Belgium 1 5%
Unknown 20 95%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 8 38%
Professor 3 14%
Researcher 2 10%
Student > Master 2 10%
Lecturer 1 5%
Other 2 10%
Unknown 3 14%
Readers by discipline Count As %
Agricultural and Biological Sciences 9 43%
Medicine and Dentistry 3 14%
Biochemistry, Genetics and Molecular Biology 3 14%
Computer Science 1 5%
Immunology and Microbiology 1 5%
Other 1 5%
Unknown 3 14%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 February 2015.
All research outputs
#11,372,809
of 12,786,466 outputs
Outputs from Hereditary Cancer in Clinical Practice
#122
of 139 outputs
Outputs of similar age
#178,765
of 215,541 outputs
Outputs of similar age from Hereditary Cancer in Clinical Practice
#2
of 2 outputs
Altmetric has tracked 12,786,466 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 139 research outputs from this source. They receive a mean Attention Score of 2.7. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 215,541 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 2 others from the same source and published within six weeks on either side of this one.